Michelle Petri, MD
Enriched profileProfessor of Medicine; Director, Johns Hopkins Lupus Center · Johns Hopkins University School of Medicine
Michelle Petri is Professor of Medicine; Director, Johns Hopkins Lupus Center at Johns Hopkins University School of Medicine. OpenAlex indexes 985 publications with 75,492 citations (h-index 137); ClinicalTrials.gov lists 10 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Rheumatology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Michelle Petri, MD, is Professor of Medicine at Johns Hopkins University School of Medicine. The public record shows 985 publications with 75,492 citations (h-index 137), centered on Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies, Monoclonal and Polyclonal Antibodies Research. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 27 companies, 13 NIH-funded awards (1990–2020).
- Most recent indexed publication: 2026 · Arthritis care & research
- Top research focus: Systemic Lupus Erythematosus Research
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 27 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 125 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 567.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
Sponsor: GlaxoSmithKline
- International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus
Sponsor: Assistance Publique - Hôpitaux de Paris
- Levothyroxine in Pregnant SLE Patients
Sponsor: Johns Hopkins University
Industry payments
Updated 27 Aug 2026
27 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202511 payments$39,551openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20258 payments$20,017openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year20256 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Antiparasitic
36.7%Antimalarial36.7%Hydroxychloroquine Sulfate100%Part D≥161 patientsCardiovascular
28.7%Statin7.9%Atorvastatin Calcium58%Pravastatin Sodium42%Part D≥21 patientsBeta blocker5.3%Metoprolol Succinate100%Part D≥18 patientsMetabolism & gastrointestinal
13.2%Corticosteroid5.7%Prednisone100%Part D≥24 patientsH2 blocker4.3%Famotidine100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
13 NIH research awards on record, funded 1990–2020 per NIH RePORTER. The latest:
- Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)
New York University School of Medicine
FY2026$1,149,761UC2AR081039 - Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)
New York University School of Medicine
FY2025$1,249,871UC2AR081039 - Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)
New York University School of Medicine
FY2024$600,000UC2AR081039
Congress activity
Updated 27 Aug 2026
3 congress contributions (2019–2024) across ASH per OpenAlex. The most recent:
- Genetic or Epigenetic CR1 Deficiency Defines Catastrophic Antiphospholipid Syndrome (CAPS) and Response to Complement Inhibition
ASH Annual Meeting
ASH2024Co-author - Rare Germline Mutations in Complement Regulatory Genes Make the Antiphospholipid Syndrome Catastrophic
ASH Annual Meeting
ASH2019Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Role of Prednisone and 25-Hydroxyvitamin D on Bone Mineral Density and Osteoporosis in Systemic Lupus Erythematosus.
Arthritis care & research
Article2026 - Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation.
Lupus science & medicine
Article2026 - Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.
Arthritis & rheumatology (Hoboken, N.J.)
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03
- 04Mortality in systemic lupus erythematosus1,190 citations2006
- 05Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus1,165 citations2005
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/michelle-petri-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Michelle-Petri-39048308
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/p/DBO0K-sJjg-
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/posts/bonniefeldman_michelle-petri-md-on-improving-outcomes-activity-7027028933443289088-nvXp
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/congress-of-clinical-rheumatology_join-michelle-petri-md-mph-and-our-activity-7290376519359623168-OGgI
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- MPH
Johns Hopkins Bloomberg School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsrheumatology.org ↗
Editorial & leadership roles
journal and society appointments- Ad hoc peer reviewer for Annals of Internal Medicine
JAMA, Lancet, and other journals (no standing editorial board seat identified)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hopkinslupus.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sliccgroup.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →the-rheumatologist.org ↗
Secondary affiliations
appointments beyond the home institution- Director
Hopkins Lupus Cohort (longitudinal NIH-funded study, 2,000+ SLE patients)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsrheumatology.org ↗ - Co-Director
Hopkins Lupus Pregnancy Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lupus.org ↗ - Member
Systemic Lupus International Collaborating Clinics (SLICC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sliccgroup.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →expertperspectives.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vumedi.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rheumnow.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Kenneth Pienta, MD
Johns Hopkins University School of Medicine
Harry Quigley, MD
Johns Hopkins University School of Medicine
Constantine Lyketsos, MD
Johns Hopkins University School of Medicine